PEER-REVIEW | SKIN REJUVENATION |
Figure 1 (A) Before combination treatment with Hybrid Energy and injections of hyaluronic acid, and (B) 10 days after second treatment
effect. The skin generates a healing process leading to fibroblast activation and promotes the production of new collagen and hyaluronic acid. The microneedles penetrate the skin enabling efficient,
Figure 2 (A) Before treatment with Hybrid Energy for peri-orbital wrinkles and lack of volume, and (B) 1.5 months after three treatments
Figure 3 (A) Before treatment with Hybrid Energy for neck skin tightening, and (B) after 6 treatments
uniform, and homogenous penetration coverage with minimal to no pain or bleeding. HE (microneedles and electrical energy) creates invisible microwounds in the dermal layer characterized by optimal dermal impact and minimal epidermal effect. The microwounds are surrounded by healthy unaffected skin areas, which function as healing centers promoting effective neocollagenesis and skin renewal. The Hybrid Energy treatment triggers the body’s natural healing response mechanism in a safe and effective process, with minimal pain and side-effects. The combination of RF and an additional non-thermal
electrical energy enhances skin penetration as well as the clinical effect and wound healing process. An increased energy input is achieved without increasing RF heating but through a chemical reaction. The electrical energy stimulates a chemical reaction between the skin’s fluids and salts. A controlled, mild change of pH (generating an alkaline environment due to generation of OH), occurs in the dermis. This chemical change creates fractional, cold electro-coagulation zones in the tissue. The electrical effect and the RF thermal effect both
energy applied directly to the specific target area,
enhancing the total clinical effect. The result is dermal volumizing through targeted thermal skin restructuring reinforced by deep volume refilling. A typical treatment starts with cleansing the treatment
area but does not require a numbing cream or local anesthesia. The energy is delivered via an array of microneedles
0.6 mm in length. There are two types of needle tips: 6x6 microneedles (total of 36) or 6x2 microneedles (total of 12) to treat small focused and delicate areas. The RF energy may be adjusted according to the individual’s needs by controlling the power (up to 62 mJ/pin) and the exposure time (units in ms). Pulses may be overlapped, and several passes may be performed. The penetration of the needles with the radiofrequency energy, followed by an electrical current create a wound
A typical
treatment starts with cleansing the treatment area but does not require a numbing cream or local anesthesia.
Figure 4 (A) Before treatment with Hybrid Energy, (B) a slight erythema is visible immediately after the treatment that (C) subsides one hour later
generate an ongoing skin healing process, involving fibroblast activation, promoting production of new collagen and hyaluronic acid. The procedure, therefore, benefits from two types of minimal invisible micro ablation ‘generators’ affecting the skin and causing the required trigger to stimulate natural healing and skin renewal. Recently, three peer reviewed papers were published; the
first, ‘Ex vivo study of hybrid energy technology using a human skin model’, published in the European Journal of Dermatology, 2014, validated significant collagen remodeling and an increase in hyaluronic acid with the use of hybrid energy20
. In other words, natural volume achieved from
within together with a significant increase in epidermal renewal. The second study, ‘VoluDerm microneedle technology for skin treatments — in vivo histological evidence’, published in the Journal of Cosmetics and Laser Therapy, 2015, presented immediate epidermal and dermal effects and complete healing of the ablation zones after 14 days for all energy levels21
. In the third and final study,
‘Voluderm microneedle technology for treating skin laxity and wrinkles — initial clinical experience’, published in Jacobs Journal of Experimental Dermatology, 2015, Dr. Shapiro shares his clinical experience and concludes that
42
August/September 2015 |
prime-journal.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64